MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/js9.0000000000003130

Медицинская библиотека · International journal of surgery (London, England) · 2025

Clinical trial landscape analysis of stem cell therapy for autoimmune rheumatic diseases.

Xu Jia, Wang Huimin, Chen Jin, Wang Qiao, Chen Xiaoyong

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Autoimmune rheumatic diseases (ARDs), including rheumatoid arthritis and osteoarthritis, are debilitating conditions with limited curative options. Stem cell therapy offers promising regenerative and immunomodulatory benefits.

METHODS

We analyzed global clinical trial data from the Informa Trialtrove database up to 31 March 2025, identifying 449 relevant trials on stem cell therapy for ARDs. Trials were assessed by phase, disease type, stem cell source, and geographic distribution.

RESULTS

Most trials employed mesenchymal stem cells (75.8%), with osteoarthritis (46.7%) and rheumatoid arthritis (12.6%) being the most targeted conditions. China led trial activity (26.7%), driven by supportive policies and funding. While 58.8% of trials were completed, 13.1% were terminated, often due to recruitment or funding limitations. Innovations such as CAR-MSCs, iPSC-derived therapies, and exosome-based strategies are expanding the therapeutic frontier.

CONCLUSION

Stem cell therapy is rapidly advancing in ARDs, supported by growing clinical evidence and technological innovations. However, standardized, multicenter phase III trials are essential to confirm long-term efficacy and safety. This evolving landscape holds potential to transform AIRD management.

Для цитирования: Xu Jia, Wang Huimin, Chen Jin, Wang Qiao, Chen Xiaoyong. Clinical trial landscape analysis of stem cell therapy for autoimmune rheumatic diseases.. International journal of surgery (London, England). 2025. DOI: 10.1097/js9.0000000000003130.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.